Natural killer cell function in cancer patients treated with natural leukocyte interferon-alpha. 1986

C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching

UI MeSH Term Description Entries
D007370 Interferon Type I Interferon secreted by leukocytes, fibroblasts, or lymphoblasts in response to viruses or interferon inducers other than mitogens, antigens, or allo-antigens. They include alpha- and beta-interferons (INTERFERON-ALPHA and INTERFERON-BETA). Interferons Type I,Type I Interferon,Type I Interferons,Interferon, Type I,Interferons, Type I
D007694 Killer Cells, Natural Bone marrow-derived lymphocytes that possess cytotoxic properties, classically directed against transformed and virus-infected cells. Unlike T CELLS; and B CELLS; NK CELLS are not antigen specific. The cytotoxicity of natural killer cells is determined by the collective signaling of an array of inhibitory and stimulatory CELL SURFACE RECEPTORS. A subset of T-LYMPHOCYTES referred to as NATURAL KILLER T CELLS shares some of the properties of this cell type. NK Cells,Natural Killer Cells,Cell, NK,Cell, Natural Killer,Cells, NK,Cells, Natural Killer,Killer Cell, Natural,NK Cell,Natural Killer Cell
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching
November 1985, Clinical immunology and immunopathology,
C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching
November 1983, Journal of the National Cancer Institute,
C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching
September 1983, Annals of neurology,
C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching
June 1986, Clinical immunology and immunopathology,
C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching
August 1991, British journal of haematology,
C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching
July 1986, Blood,
C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching
September 1991, European journal of haematology,
C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching
January 1997, Human antibodies,
C Ching, and C Wong, and M V Cruz, and D Sato, and G K Wong, and R Herberman, and N Ching
May 1982, Journal of the National Cancer Institute,
Copied contents to your clipboard!